Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 77901-77950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05658237
Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)
NAActive, not recruiting
10 participants
Started: Feb 17, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05677269
The (Cost-)Effectiveness of Surgical Excision of Colorectal Endometriosis Compared to ART Treatment Trajectory
N/ARecruiting
339 participants
Started: Feb 17, 2023 · Completed: Jan 1, 2029
3 conditions8 sponsors10 locations
NCT05501743
Evaluation of the Efficacy of an Intra-articular Injection of Autologous Microfat Combined With Autologous Platelet-enriched Plasma in the Treatment of Radiocarpal Osteoarthritis: a Randomized Controlled Non-inferiority Trial Versus Total Wrist Denervation (Established Standard Treatment).
PHASE2Recruiting
36 participants
Started: Feb 17, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05427487
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
PHASE1Recruiting
70 participants
Started: Feb 17, 2023 · Completed: Nov 30, 2026
3 conditions2 sponsors3 locations
NCT05749822
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
PHASE2/PHASE3Recruiting
104 participants
Started: Feb 17, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor12 locations
NCT05905926
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C
PHASE3Enrolling by invitation
150 participants
Started: Feb 17, 2023 · Completed: Oct 31, 2031
1 condition1 sponsor20 locations
NCT05952583
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
N/ARecruiting
274 participants
Started: Feb 17, 2023 · Completed: Mar 1, 2028
4 conditions6 sponsors6 locations
NCT05795036
Using a mHealth Intervention to Promote Physical Activity in Phase III Cardiac Rehabilitation Clients
NARecruiting
46 participants
Started: Feb 17, 2023 · Completed: Dec 17, 2025
2 conditions1 sponsor1 location
NCT05304195
Exploration of GCase Activity to Identify a Subpopulation Eligible for a Therapeutic Trial in Dementia with Lewy Bodies
N/ARecruiting
236 participants
Started: Feb 17, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05704764
Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances
NAActive, not recruiting
70 participants
Started: Feb 17, 2023 · Completed: Jun 30, 2026
3 conditions4 sponsors2 locations
NCT06012552
Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.
PHASE2Recruiting
140 participants
Started: Feb 17, 2023 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT05730803
Displacement of Iodine Balance Value During Pregnancy and the Mechanism of Breast Iodine Homeostasis During Lactation
N/ANot yet recruiting
1,200 participants
Started: Feb 17, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT05777655
Improving Adherence to Statin Therapy Through a Medication Management Application
NARecruiting
250 participants
Started: Feb 17, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05818605
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
NARecruiting
70 participants
Started: Feb 17, 2023 · Completed: Mar 1, 2027
1 condition3 sponsors1 location
NCT05498220
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2Active, not recruiting
5 participants
Started: Feb 17, 2023 · Completed: Nov 7, 2026
1 condition2 sponsors1 location
NCT06702683
The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
N/ARecruiting
112 participants
Started: Feb 17, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06112236
Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special Focus on Hypophosphatemia
N/AActive, not recruiting
250 participants
Started: Feb 17, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05814419
Familial Hyperlipidemia Family Registry
N/AActive, not recruiting
11 participants
Started: Feb 17, 2023 · Completed: Apr 26, 2025
1 condition1 sponsor1 location
NCT05716191
Study on the Relationship Between Iodine Nutrition and Thyroid Diseases in the Elderly
N/ARecruiting
1,000 participants
Started: Feb 17, 2023 · Completed: Dec 30, 2025
2 conditions3 sponsors3 locations
NCT05611697
Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity
NARecruiting
220 participants
Started: Feb 17, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor2 locations
NCT05737563
PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC
PHASE3Recruiting
380 participants
Started: Feb 17, 2023 · Completed: Feb 17, 2026
1 condition3 sponsors1 location
NCT05624385
MRgFUS Thalamotomy for Therapy-Resistant Tremor-related Disease With Low SDR Value
NARecruiting
20 participants
Started: Feb 17, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05679024
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
PHASE3Recruiting
1,400 participants
Started: Feb 17, 2023 · Completed: Dec 31, 2028
9 conditions1 sponsor34 locations
NCT05532397
Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma
NARecruiting
10 participants
Started: Feb 17, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT06787352
Ultrasound Features of Endometriosis of the Uterosacral Ligaments
N/AActive, not recruiting
228 participants
Started: Feb 16, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05428176
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
NARecruiting
332 participants
Started: Feb 16, 2023 · Completed: Jun 30, 2027
4 conditions2 sponsors4 locations
NCT05730608
18F-FDG PET/CT Imaging for Breast Cancer
NARecruiting
300 participants
Started: Feb 16, 2023 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT05012982
Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction
NARecruiting
20 participants
Started: Feb 16, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT06161779
Submental Flap for the Reconstruction of Hypopharyngectomy
NARecruiting
40 participants
Started: Feb 16, 2023 · Completed: Feb 16, 2030
1 condition1 sponsor1 location
NCT05558124
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
PHASE1Recruiting
18 participants
Started: Feb 16, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05668676
Effect of Short-Term Prednisone Therapy on C-Reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers ( CORTAHF )
PHASE2/PHASE3Recruiting
120 participants
Started: Feb 16, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT06154317
Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)
N/ARecruiting
30 participants
Started: Feb 16, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT05319639
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
PHASE1/PHASE2Recruiting
51 participants
Started: Feb 16, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05521529
Cushing's Syndrome Before and After Treatment (CORRECT)
N/ARecruiting
20 participants
Started: Feb 16, 2023 · Completed: Nov 30, 2032
1 condition2 sponsors1 location
NCT05009797
PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation
N/ARecruiting
750 participants
Started: Feb 16, 2023 · Completed: Feb 28, 2031
1 condition1 sponsor1 location
NCT05746078
Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients with Mild to Moderate Facial Ptosis.
N/ARecruiting
99 participants
Started: Feb 16, 2023 · Completed: Mar 31, 2029
2 conditions2 sponsors3 locations
NCT05699785
Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy
NARecruiting
500 participants
Started: Feb 16, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor2 locations
NCT06315140
Assessing and Addressing Community Exposures to Environmental Contaminants
NARecruiting
400 participants
Started: Feb 16, 2023 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT05608525
Upper Limb tDCS in Chronic Stroke Patients (NOURISH)
NARecruiting
51 participants
Started: Feb 16, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05817214
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
PHASE2Recruiting
35 participants
Started: Feb 16, 2023 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05624190
Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization
PHASE4Recruiting
256 participants
Started: Feb 16, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT05872776
BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation
NARecruiting
50 participants
Started: Feb 16, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor2 locations
NCT05477797
Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.
NARecruiting
420 participants
Started: Feb 16, 2023 · Completed: Jan 15, 2026
3 conditions1 sponsor1 location
NCT05614531
Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1
PHASE1/PHASE2Enrolling by invitation
12 participants
Started: Feb 16, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor2 locations
NCT05931419
High-Risk prostatE Cancer radiatiOn Versus surgERy
N/ARecruiting
837 participants
Started: Feb 16, 2023 · Completed: Jun 30, 2030
2 conditions1 sponsor29 locations
NCT06947512
Personalization of Visual Characters and Text-to-Speech (TTS) to Support Learning in Students With Reading Difficulties
NARecruiting
90 participants
Started: Feb 16, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor3 locations
NCT05816499
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Feb 16, 2023 · Completed: Dec 30, 2025
3 conditions4 sponsors5 locations
NCT05408247
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
PHASE4Recruiting
280 participants
Started: Feb 16, 2023 · Completed: Nov 30, 2026
1 condition2 sponsors3 locations
NCT05247905
Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
PHASE2Active, not recruiting
31 participants
Started: Feb 16, 2023 · Completed: Oct 1, 2033
2 conditions2 sponsors171 locations
NCT05525663
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
NARecruiting
880 participants
Started: Feb 16, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors1 location